Log in

Infinity Pharmaceuticals SEC Filings & 10K Form (NASDAQ:INFI)

$1.14
-0.02 (-1.72 %)
(As of 10/17/2019 01:04 AM ET)
Today's Range
$1.14
Now: $1.14
$1.22
50-Day Range
$1.01
MA: $1.14
$1.24
52-Week Range
$0.96
Now: $1.14
$2.75
Volume302,051 shs
Average Volume136,542 shs
Market Capitalization$65.01 million
P/E RatioN/A
Dividend YieldN/A
Beta1.82

SEC Filings

Infinity Pharmaceuticals (NASDAQ:INFI) SEC Filings

DateFilerForm TypeView
10/16/2019
6:18 PM
Agresta Samuel (Reporting)
Infinity Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
10/16/2019
6:14 PM
Agresta Samuel (Reporting)
Infinity Pharmaceuticals (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
08/22/2019
3:05 PM
Infinity Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/30/2019
7:32 AM
Infinity Pharmaceuticals (Filer)
Form 424B5
07/30/2019
6:44 AM
Infinity Pharmaceuticals (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
07/30/2019
6:35 AM
Infinity Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/28/2019
3:26 PM
Infinity Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/14/2019
3:06 PM
EVNIN ANTHONY B (Reporting)
Infinity Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/14/2019
3:06 PM
Infinity Pharmaceuticals (Issuer)
SELBY NORMAN C (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/14/2019
3:06 PM
BEIER DAVID W (Reporting)
Infinity Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/14/2019
3:05 PM
Infinity Pharmaceuticals (Issuer)
VENUTI MICHAEL C (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/14/2019
3:05 PM
BLOCH LAWRENCE E (Reporting)
Infinity Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/14/2019
3:05 PM
Infinity Pharmaceuticals (Issuer)
Kauffman Michael (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/14/2019
3:05 PM
Infinity Pharmaceuticals (Issuer)
Perkins Adelene Q (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/14/2019
3:05 PM
Berkowitz Jeffrey (Reporting)
Infinity Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/14/2019
6:32 AM
Infinity Pharmaceuticals (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
06/13/2019
3:56 PM
Infinity Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/07/2019
3:11 PM
Infinity Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/07/2019
2:16 PM
Infinity Pharmaceuticals (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
04/29/2019
11:15 PM
Infinity Pharmaceuticals (Filer)
Form EFFECT
04/24/2019
7:30 AM
Infinity Pharmaceuticals (Filer)
Form DEF 14A
04/08/2019
4:03 PM
Infinity Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/14/2019
9:10 AM
Infinity Pharmaceuticals (Filer)
Form S-3
Registration statement under Securities Act of 1933  
03/14/2019
6:38 AM
Infinity Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/14/2019
6:06 AM
Infinity Pharmaceuticals (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
03/06/2019
6:53 AM
Infinity Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/28/2019
7:00 AM
Infinity Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/07/2019
3:07 PM
Infinity Pharmaceuticals (Issuer)
Tasker Seth A (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/07/2019
3:06 PM
BLOCH LAWRENCE E (Reporting)
Infinity Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/07/2019
3:05 PM
Infinity Pharmaceuticals (Issuer)
Kutok Jeffery (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/07/2019
3:05 PM
Agresta Samuel (Reporting)
Infinity Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/07/2019
3:05 PM
Infinity Pharmaceuticals (Issuer)
Perkins Adelene Q (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/07/2019
6:46 AM
Infinity Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/17/2018
6:40 PM
BIOTECHNOLOGY VALUE FUND II LP (Reporting)
BIOTECHNOLOGY VALUE FUND L P (Reporting)
Biotechnology Value Trading Fund OS LP (Reporting)
BVF INC/IL (Reporting)
BVF PARTNERS L P/IL (Reporting)
BVF Partners OS Ltd. (Reporting)
Infinity Pharmaceuticals (Issuer)
LAMPERT MARK N (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/30/2018
5:28 PM
BIOTECHNOLOGY VALUE FUND II LP (Reporting)
BIOTECHNOLOGY VALUE FUND L P (Reporting)
Biotechnology Value Trading Fund OS LP (Reporting)
BVF INC/IL (Reporting)
BVF PARTNERS L P/IL (Reporting)
BVF Partners OS Ltd. (Reporting)
Infinity Pharmaceuticals (Issuer)
LAMPERT MARK N (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/21/2018
4:57 PM
BIOTECHNOLOGY VALUE FUND II LP (Reporting)
BIOTECHNOLOGY VALUE FUND L P (Reporting)
Biotechnology Value Trading Fund OS LP (Reporting)
BVF INC/IL (Reporting)
BVF PARTNERS L P/IL (Reporting)
BVF Partners OS Ltd. (Reporting)
Infinity Pharmaceuticals (Issuer)
LAMPERT MARK N (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/21/2018
4:24 PM
BIOTECHNOLOGY VALUE FUND L P (Filed by)
Infinity Pharmaceuticals (Subject)
Form SC 13D/A
11/15/2018
7:07 PM
BIOTECHNOLOGY VALUE FUND II LP (Reporting)
BIOTECHNOLOGY VALUE FUND L P (Reporting)
Biotechnology Value Trading Fund OS LP (Reporting)
BVF INC/IL (Reporting)
BVF PARTNERS L P/IL (Reporting)
BVF Partners OS Ltd. (Reporting)
Infinity Pharmaceuticals (Issuer)
LAMPERT MARK N (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/05/2018
2:33 PM
Infinity Pharmaceuticals (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
09/30/2018
11:00 PM
Infinity Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/07/2018
4:10 PM
Agresta Samuel (Reporting)
Infinity Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/07/2018
4:05 PM
Agresta Samuel (Reporting)
Infinity Pharmaceuticals (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
08/07/2018
3:13 PM
Infinity Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/07/2018
2:27 PM
Infinity Pharmaceuticals (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
06/26/2018
10:52 AM
Infinity Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/25/2018
4:00 PM
Infinity Pharmaceuticals (Issuer)
Kutok Jeffery (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/21/2018
5:57 PM
BIOTECHNOLOGY VALUE FUND II LP (Reporting)
BIOTECHNOLOGY VALUE FUND L P (Reporting)
Biotechnology Value Trading Fund OS LP (Reporting)
BVF INC/IL (Reporting)
BVF PARTNERS L P/IL (Reporting)
BVF Partners OS Ltd. (Reporting)
Infinity Pharmaceuticals (Issuer)
LAMPERT MARK N (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/21/2018
4:23 PM
BIOTECHNOLOGY VALUE FUND L P (Filed by)
Infinity Pharmaceuticals (Subject)
Form SC 13D/A
06/14/2018
7:37 AM
Infinity Pharmaceuticals (Issuer)
SELBY NORMAN C (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/14/2018
7:35 AM
Berkowitz Jeffrey (Reporting)
Infinity Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/14/2018
7:34 AM
Infinity Pharmaceuticals (Issuer)
SMITH IAN F (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/14/2018
7:33 AM
EVNIN ANTHONY B (Reporting)
Infinity Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/14/2018
7:32 AM
Infinity Pharmaceuticals (Issuer)
Kauffman Michael (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/14/2018
7:31 AM
Infinity Pharmaceuticals (Issuer)
VENUTI MICHAEL C (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/14/2018
7:30 AM
Infinity Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/14/2018
7:30 AM
BEIER DAVID W (Reporting)
Infinity Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/10/2018
11:15 PM
Infinity Pharmaceuticals (Filer)
Form EFFECT
05/08/2018
3:12 PM
Infinity Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/08/2018
2:36 PM
Infinity Pharmaceuticals (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
04/30/2018
3:55 PM
Infinity Pharmaceuticals (Filer)
Form S-3
Registration statement under Securities Act of 1933  
04/25/2018
7:30 AM
Infinity Pharmaceuticals (Filer)
Form DEF 14A
04/12/2018
4:29 PM
BIOTECHNOLOGY VALUE FUND L P (Filed by)
Infinity Pharmaceuticals (Subject)
Form SC 13D
04/11/2018
5:01 PM
BIOTECHNOLOGY VALUE FUND II LP (Reporting)
BIOTECHNOLOGY VALUE FUND L P (Reporting)
Biotechnology Value Trading Fund OS LP (Reporting)
BVF INC/IL (Reporting)
BVF PARTNERS L P/IL (Reporting)
BVF Partners OS Ltd. (Reporting)
Infinity Pharmaceuticals (Issuer)
LAMPERT MARK N (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/02/2018
7:22 PM
BEIER DAVID W (Reporting)
Infinity Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
04/02/2018
7:18 PM
BEIER DAVID W (Reporting)
Infinity Pharmaceuticals (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
03/15/2018
3:17 PM
Infinity Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/15/2018
2:43 PM
Infinity Pharmaceuticals (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
03/08/2018
7:39 AM
Infinity Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/07/2018
3:22 PM
Infinity Pharmaceuticals (Issuer)
Perkins Adelene Q (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/14/2018
1:35 PM
BIOTECHNOLOGY VALUE FUND L P (Filed by)
Infinity Pharmaceuticals (Subject)
Form SC 13G/A
02/14/2018
7:49 AM
Flynn James E (Filed by)
Infinity Pharmaceuticals (Subject)
Form SC 13G/A
02/13/2018
8:39 AM
FMR LLC (Filed by)
Infinity Pharmaceuticals (Subject)
Form SC 13G
02/12/2018
8:38 AM
Infinity Pharmaceuticals (Subject)
VANGUARD GROUP INC (Filed by)
Form SC 13G/A
02/08/2018
10:39 AM
Infinity Pharmaceuticals (Subject)
WELLINGTON MANAGEMENT GROUP LLP (Filed by)
Form SC 13G/A
01/09/2018
3:10 PM
Infinity Pharmaceuticals (Issuer)
Perkins Adelene Q (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/08/2018
7:41 AM
Infinity Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/07/2017
8:11 AM
BLOCH LAWRENCE E (Reporting)
Infinity Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
This page was last updated on 10/17/2019 by MarketBeat.com Staff

Featured Article: What is the balance sheet?

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel